BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12150341)

  • 1. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease.
    Basaria S; Salvatori R
    J Endocrinol Invest; 2002; 25(7):639-42. PubMed ID: 12150341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive behavior of papillary microcarcinoma in a patient with Graves' disease initially presenting as cystic neck mass.
    Braga M; Graf H; Ogata A; Batista J; Hakim NC
    J Endocrinol Invest; 2002 Mar; 25(3):250-3. PubMed ID: 11936468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
    Valenti TM; Macchia E; Pisa R; Bucalo ML; Russo V; Colletti I; Compagno V; Abbadi V; Donatelli M
    J Endocrinol Invest; 1999 Oct; 22(9):701-4. PubMed ID: 10595835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pulmonary metastatic thyroid cancer complicated with Graves' disease.
    Suzuki K; Nakagawa O; Aizawa Y
    Endocr J; 2001 Apr; 48(2):175-9. PubMed ID: 11456264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
    Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
    J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' disease, thyroid nodules and thyroid cancer.
    Belfiore A; Russo D; Vigneri R; Filetti S
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):711-8. PubMed ID: 11895209
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of Graves' disease and papillary thyroid carcinoma with predominant production of thyroid-stimulation-blocking antibodies (TSBAb) persisted after total thyroidectomy.
    Nakamura S; Ishiyama-Takuno M; Kosaka J; Kondo K; Horiya Y; Hara S; Shima H; Shiraki T
    Endocrinol Jpn; 1992 Feb; 39(1):133-9. PubMed ID: 1351465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of post-partum thyrotoxicosis.
    Azizi F
    J Endocrinol Invest; 2006 Mar; 29(3):244-7. PubMed ID: 16682838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' disease and concurrent thyroid carcinoma. The importance of thyroid scintigraphy in Graves' disease.
    Joseph UA; Jhingran SG
    Clin Nucl Med; 1995 May; 20(5):416-8. PubMed ID: 7628144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Graves' disease and papillary thyroid cancer--coincidence or association?].
    Kinkel B; Bucerius J; Risse JH
    Dtsch Med Wochenschr; 2007 May; 132(18):983-6. PubMed ID: 17457781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual initial manifestation of metastatic papillary thyroid carcinoma: radioiodine uptake in lymph node metastatic lesions in a patient with Graves' disease.
    Newman SL; Griffith AY; Herbst AB; Yeh IT; Kukora JS
    Endocr Pract; 2002; 8(4):304-6. PubMed ID: 12173918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
    Yunusa GH; Kotze T; Brink A
    Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Tc-99m-pertechnetate scan visualization of gross neck metastases from microcarcinoma papillare and another papillary carcinoma of tall cell variant scintigraphically presented like small warm nodule in Graves disease patient.
    Marković V; Eterović D; Punda A; Pešutić-Pisac V; Kuna T
    Clin Nucl Med; 2010 Nov; 35(11):858-61. PubMed ID: 20940542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotoxicosis caused by thyroid cancer.
    Paul SJ; Sisson JC
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):593-612. PubMed ID: 2261908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyroidism: A Review.
    Lee SY; Pearce EN
    JAMA; 2023 Oct; 330(15):1472-1483. PubMed ID: 37847271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous diffuse sclerosis variant of papillary thyroid carcinoma and diffuse toxic hyperplasia (Graves' disease).
    Paner GP; Hunt JL; Ciesla MC; DeJong S; LiVolsi V
    Endocr Pathol; 2004; 15(1):77-82. PubMed ID: 15067179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing thyrotoxicosis in the acute medical setting.
    Napier C
    Acute Med; 2018; 17(1):44-48. PubMed ID: 29589605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthyroid Graves' disease after hemithyroidectomy for papillary carcinoma: report of three cases.
    Misaki T; Iwata M; Kasagi K; Iida Y; Akamizu T; Kosugi S; Konishi J
    Endocr J; 2000 Apr; 47(2):191-5. PubMed ID: 10943744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated radioiodine therapy for hyperthyroidism caused by widespread metastatic follicular thyroid carcinoma.
    Nishihara E; Amino N; Miyauchi A
    Thyroid; 2010 May; 20(5):569-70. PubMed ID: 20384491
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.